Supplemental Data

  1. Longitudinal, global transcriptomic profiling of preclinical systemic sclerosis provides insights into molecular changes associated with disease progression
  2. Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalization over time. Ann Rheum Dis. 2022 Apr;81(4):516-523.
  3. Large-scale characterization of systemic sclerosis serum protein profile: Comparison to peripheral blood cell transcriptome and correlations with skin/lung fibrosis. Arthritis Rheumatol. 2021 Apr;73(4):660-670.
  4.  Global skin gene expression profile of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis. 2019 Nov 25. pii: annrheumdis-2019-215894. Ann Rheum Dis. 2020 Mar;79(3):379-386.
  5. Treatment with myeloablation followed by autologous stem cell transplantation normalizes the systemic sclerosis molecular signatures. Ann Rheum Dis. 2019 Oct;78(10):1371-1378
  6. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation. J Exp Med. 2020 Feb 3;217(2).
  7. CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients with Early Systemic Sclerosis Data from Two Independent Cohorts. Arthritis Rheumatol. 2017 Sep;69(9):1871-1878.
  8. Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis. Arthritis Rheumatol. 2015 Nov;67(11):3016-26
  9. Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis. Arthritis Rheum. 2013 Nov;65(11):2917-27
  10. Secondary use of existing public microarray data to predict outcome for hepatocellular carcinoma. J Surg Res. 2014 May 1;188(1):137-42
  11. Systemic sclerosis and Lupus: Points in an interferon-mediated continuum. Arthritis Rheum, 2010, 62:589-598
  12. Major histocompatibility complex (MHC) class II alleles and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010 69: 822-827
  13. Signatures of differentially regulated interferon gene expression and vasculotropism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford), 2006, 45: 694-702
  14. Clinically discordant scleroderma monozygotic twins show concordance for fibroblast gene expression profiles. Arthritis Rheum, 2005, 52: 3305-3314
  15. Classification analysis of the transcriptosome of non-lesional cultured dermal fibroblasts from scleroderma patients with early disease. Arthritis Rheum 2005, 52:865-876